Seminars and Events
Joklik Distinguished Lectureship
The Joklik Distinguished Lectureship honors and commemorates the myriad contributions of Dr. Bill (Wolfgang Karl) Joklik to the Department of Microbiology and Immunology at Duke, which he chaired; to the institution, specifically for his role as the co-founder of the Duke Comprehensive Cancer Center; and to the broader microbiology community for his research program in virology, service in founding the American Society for Virology, and for his editorial work for the journal Virology and the seminal text, Zinsser's Microbiology.
Together with the Nobel Laureate Paul Berg, Dr. Joklik was responsible for the discovery of the enzyme terminal transferase. Dr. Joklik was the first to examine the mechanism of action of interferon--the first cytokine to be recognized in molecular terms in 1964--and was recently conferred an honorary member of the International Society for Interferon and Cytokine Research. Much of his scientific career was devoted to the development and application of molecular virology with a focus on reovirus and vaccinia. Many alumni who trained in his laboratory are leading investigators in biomedical research, including Joseph Nevins, PhD, who is the Barbara Levine University Professor of Breast Cancer Genomics.
Dr. Joklik is currently a James B. Duke Professor Emeritus of Molecular Genetics and Microbiology, a member of the National Academy of Sciences, and an active member of the community.
List of Speakers
First Annual Lecture - September 25, 2010
“Poxviruses do it all in the cytoplasm”
Dr. Bernard Moss
National Institute of Allergy and Infectious Diseases
Second Annual Lecture - September 23, 2011
“Positive-strand RNA viruses: Dominant drug targets and novel routes of viral spread”
Karla Kirkegaard, PhD
Stanford University School of Medicine
Third Annual Lecture - September 21, 2012
"Cell entry of non-enveloped viruses"
Stephen Harrison, PhD
Harvard Medical School
Fourth Annual Lecture - September 7, 2013
"Exploiting replication deficiencies to illuminate HIV/host interactions"
Michael Malim, DPhil
King's College, London School of Medicine